Hospital-acquired and Transplant Infections

12:30 PM

375

CT Imaging in Ventilator Associated Pneumonia
Steven Gordon, MD, FIDSA ; Ruffin Graham, MD ; Susan Rehm, MD ; Rudy Tedja, DO ; David van Duin, MD, PhD

12:30 PM

376

Careful Attention to Serial Interpretation of Chest X-rays (CXR) May Alter Surveillance Reporting of Ventilator-associated Pneumonia (VAP) Compared to Use of Radiographic Reports
Eugene Berkowitz, MD ; Elaine Chang, NP ; Seth Clemens, MD ; Jesse Jacob, MD ; Kenneth Leeper, Jr, MD ; Monica Maher, RN ; James Steinberg, MD

12:30 PM

377

Investigation of an Outbreak of Multidrug Resistant Acinetobacter baumannii in a Surgical Intensive Care Unit
Peter Axelrod, MD ; Jihoon Baang, MD ; Robert Bonomo, MD ; Georgia Dash, RN, BSN, MS ; Brooke Decker, MD ; Thomas Fekete, MD ; Allan Truant, PhD

12:30 PM

378

Outcome of Intensive Care Unit (ICU) patients with Hospital-Acquired Pneumonia (HAP) is not related to causative organism: Results from the IMPACT HAP Study
Kimbal Ford, PharmD ; Nadia Haque, Pharm, D ; Daniel Kett, MD ; Julie Mangino, MD ; Paula Peyrani, MD ; Julio A. Ramirez, MD ; Ernesto Scerpella, MD ; The IMPACT HAP Study Group ; Verna Welch, PhD, MPH ; Marc Zervos, MD

12:30 PM

379

Regional Pathogen Variations in a Large Phase III Hospital-acquired Pneumonia Clinical Program: The ATTAIN Experience
Steven Barriere ; Marcelo Rocha, MD ; Ethan Rubinstein ; Jean-Louis Vincent, MD

12:30 PM

380

Incidence and Etiology of Early (E) and Late (L) Onset Ventilator-Associated Pneumonia (VAP) in a University Hospital
Patricio Cabral, MD ; Martin Gnoni, MD ; Alpa Patel, PharmD ; Paula Peyrani, MD ; Julio Ramirez, MD ; James Snyder, PhD ; Timothy Wiemken, MPH

12:30 PM

381

Clinical Outcomes of Patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP Study
Marty Allen, MD ; Patricio Cabral, MD ; Kimbal Ford, PharmD ; Martin Gnoni, MD ; Daniel Kett, MD ; Julie Mangino, MD ; Mehdi Mirsaeidi, MD ; Paula Peyrani, MD ; Julio Ramirez, MD ; Ernesto Scerpella, MD ; the IMPACT-HAP Study Group ; Marcus Zervos, MD

12:30 PM

382

Methodological Deficiencies and Quality of Reporting in Published Clinical Trials of Antibacterial Drugs for the Treatment of Nosocomial Pneumonia
Scott Komo, DrPH ; Alfred Sorbello, DO, MPH ; Thamban Valappil, PhD

12:30 PM

383

Applicability of IDSA/ATS Recommendations for HAP and HCAP and Impact of Sputum Cultures on De-Escalation Therapy in a Non-Intensive Care Unit Setting
Tara Babu, MD ; Roy Guharoy, PharmD, MBA ; Elizabeth Radigan, PharmD ; Gail Scully, MD, MPH

12:30 PM

384

Efficacy of Vancomycin Therapy for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Ventilator-Associated Pneumonia (VAP) with Vancomycin MICs </= 0.5 vs. Vancomycin MICs >/= 1
Nitin Bhanot, MD, MPH ; Noreen Chan-Tompkins, PharmD ; Jenna Ferrara, PharmD ; Cheryl Herbert, RN, CIC ; Andrew Sahud, MD

12:30 PM

385

Prevalence of Pseudomonas in Aspiration Pneumonia
Muhammad Gill, MD ; Majid Ibrahim, MD ; Kell Julliard, MA ; Tehmina Malik, MD ; Muhammad Muzaffar, MD ; Smiti Parikh, PharmD ; Rohit Sharma, MD ; David Tompkins, MD ; Ernest Visconti, MD

12:30 PM

386

Doripenem 1 g infused for 4 hours (h) in the Treatment of Nosocomial Pneumonia/Ventilator Associated Pneumonia (NP/VAP) due to Acinetobacter baumannii (A. baumannii)
Mary Ambruzs, RN, BSN ; Susan Nicholson, MD ; Janet Peterson, PhD ; Jim Xiang, PhD ; Behin Yektashenas, PharmD

12:30 PM

387

The Clinical Value of Pneumonia Severity Index and CURB-65 Measurement in Community Acquired pneumonia and Health-Care Associated Pneumonia
Jung-Yien Chien, MD, MS ; Yu-Min Chuang, MD ; Ya-Chi Ho, MD, MS

12:30 PM

388

Nephrotoxicity in Intensive Care Unit (ICU) Patients with Hospital-Acquired Pneumonia (HAP)
Scott Devine, RPh, MPH, PhD ; Kimbal Ford, PharmD ; Nadia Haque, Pharm, D ; Carol Moore, PharmD ; Paola Osaki Kiyan, MD ; Paula Peyrani, MD ; Julio A. Ramirez, MD ; Katherine Reyes, MD ; Ernesto Scerpella, MD ; Verna Welch, PhD, MPH ; Marcus Zervos, MD

12:30 PM

389

Effect of Age and Baseline Bacteremia Status on the Outcomes and Mortality of Hospital-acquired Pneumonia in the ATTAIN Studies
Steven Barriere ; G Corey, MD ; Fredric Genter, PhD ; Galia Rahav, MD ; Ethan Rubinstein, MD, L.LB

12:30 PM

390

Epidemiology and Outcomes of Healthcare-Associated Pneumonia, Bach Mai Hospital, Vietnam
Truong Anh Thu, MD, MPH ; Lennox Archibald, MD, PhD ; Nguyen Gia Binh, MD, PhD ; Nguyen Viet Hung, MD, PhD

12:30 PM

391

Mortality in Patients with Ventilator-Associated Pneumonia and Severe Sepsis is Determined by the Number of Organ Failures
Patricio Cabral, MD ; Martin Gnoni, MD ; Paula Peyrani, MD ; Julio Ramirez, MD ; Silvia Uriarte, PhD ; Timothy Wiemken, MPH

12:30 PM

392

Management of Health Care Associated Pneumonia (HCAP): Economic Assessment of Compliance to the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) Guidelines
and the IMPACT-HAP Study Group ; Ennie Cano, PharmD ; Andrea Castelblanco, MD ; Kimbal Ford, PharmD ; Daniel H. Kett, MD ; Julie Mangino, MD ; Paula Peyrani, MD ; Andrew Quartin, MD, MPH ; Julio A. Ramirez, MD ; Ernesto Scerpella, MD ; Marcus Zervos, MD

12:30 PM

393

SNPs Associated with a High IL-6, Low IL-10 Cytokine Pattern Predispose Lung Transplant (LT) Recipients to Pneumonia due to Moulds
Cornelius Clancy, MD ; Dm Girnita, MD, PhD ; Dimitra Mitsani, MD ; M. Hong Nguyen, MD ; Adriana Zeevi, PhD

12:30 PM

394

Mannose Binding Lectin and Adverse Outcomes after Liver Transplant
Roberta O'Connor, PhD ; Swetal Patel, MD ; Robin Ruthazer, MPH ; David Snydman, MD, FIDSA ; Honorine Ward, MD

12:30 PM

395

Randomized Prospective Trial of Depleting Antibody Induction in Kidney and Pancreas Transplantation: Infectious Complications
William Doares, PharmD ; Alan Farney, MD, PhD ; Lois Hart, BS ; Jeffrey Rogers, MD ; Robert Stratta, MD

12:30 PM

396

The Clinical Spectrum of BK Virus Infection after Hematopoietic Stem Cell Transplant (HSCT)
C Bertozzi-Villa, Undergraduate ; Pursell K, MD ; P O'Donnell, MD ; C Ramaprasad, MD, MPH ; K Swanson, BS ; K Van Besien, MD

12:30 PM

397

Infectious Complications and Outcome of Lung Transplantation (LT) in Elderly Patients Receiving Alemtuzumab
C Clancy, MD ; M. Hong Nguyen, MD ; Aniket Vadnerkar, MD

12:30 PM

398

Short Course Cidofovir (CDV) is a Feasible Option for Treatment of Adenovirus (ADV) Nephropathy in Select Solid Organ Transplant Recipients
Senu Apewokin, MD ; Mary Prendergast, MD ; Brian Quinn, MD

12:30 PM

399

Clinical Outcomes without CMV Prophylaxis in Living-donor Liver Transplant Recipients in Korea
Kyung-Wook Hong, MD

12:30 PM

400

Relationship Between CMV-specific T-cell Immunity and Allograft Rejection in Lung Transplant Patients
Sharon Chen, MD ; Vivian de Leon, BS ; Gundeep Dhillon, MD ; David Lewis, MD ; Lan Liu, BS ; David Weill, MD

12:30 PM

401

Occurrence of CMV Viremia in Patients More than 1 Year Post-Solid Organ Transplantation
Todd Barton, MD ; Emily Blumberg, MD, FIDSA ; Dana Blyth, MD ; Wendi Dull, * ; Leanne Gasink, MD ; Ingi Lee, MD, MSCE ; Patrice Pfeiffenberger, CRNP ; Karen Sims, MD, PhD ; Vivianna Van Deerlin, MD

12:30 PM

402

Single Nucleotide Polymorphism (SNP) Associated with Elevated IFN-γ Levels is a Risk Factor for CMV Disease in Non-mismatch Lung Transplant (LT) Recipients
Cornelius Clancy, MD ; Dm Girnita, MD, PhD ; Dimitra Mitsani, MD ; M. Hong Nguyen, MD ; Adriana Zeevi, PhD

12:30 PM

403

Invasive Fusariosis (FUS) in Patients (pts) with Hematologic Malignancy (HM) at MD Anderson Cancer Center: The Last Decade
Marcela Campo, MD ; Dimitrios Kontoyiannis, MD, ScD, FIDSA ; Russell Lewis, PharmD

12:30 PM

404

Trends in epidemiology and sites of involvement by invasive fungal infections in patients with hematological malignancies: a 20-year autopsy study
Georgios Chamilos, MD ; Dimitrios Kontoyiannis, MD, ScD, FIDSA ; Konstantino Leventakos, MD ; Russell Lewis, PharmD ; Mario Luna, MD ; Issam Raad, MD ; Pheroze Tamboli, MD

12:30 PM

405

Geoclimatic Influences on Invasive Aspergillosis Following Hematopoietic Stem Cell Transplantation
Michael Boeckh, MD, FIDSA ; Dimitrios Kontoyiannis, MD, ScD, FIDSA ; Hong Li, MD, MSPH ; Kieren A. Marr, MD, FIDSA ; Motomi Mori, PhD ; Anil Panackal, MD, ScM, FACP ; Cheryl Perego, MT(ASCP), MPH, CIC

12:30 PM

406

Computed Tomography (CT) Findings of Invasive Pulmonary Aspergillosis (IPA) in Solid Organ Transplant (SOT) Recipients
Barbara Alexander, MD, MHS, FIDSA ; David Andes, MD ; John Baddley, MD, MSPH ; Erik Dubberke, MD, MSPh ; J Harrison, MS-IV ; Dimitrios Kontoyiannis, MD, ScD, FIDSA ; Peter Pappas, MD

12:30 PM

407

Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring (VOR TDM) in Lung Transplant (LT) Recipients
Cornelius Clancy, MD ; Dimitra Mitsani, MD ; M. Hong Nguyen, MD ; Yoshiya Toyoda, MD, PhD

12:30 PM

408

Disseminated Coccidioidomycosis prior to Transplantation is a Risk Factor for Reactivation after Solid Organ Transplantation
Janis Blair, MD ; Shimon Kusne, MD ; Maria Teresa Seville, MD ; Holenarasipur Vikram, MD

12:30 PM

409

Histoplasmosis in Solid Organ Transplant Recipients
John Baddley, MD, MSPH ; Matthew McCall, MD ; Peter Pappas, MD

12:30 PM

410

Hepatic Dysfunction in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients: Role of Liver Biopsy (LBx) and Risk of Voriconazole Use
George Alangaden, MD ; Zaid Al-Kadhimi, MD ; Karanpreet Bains, MD ; Pranatharthi Chandrasekar, MD ; Mayur Ramesh, MD

12:30 PM

411

Invasive Fungal Infections in Liver Transplant Recipients 2003-2007: Incidence, mortality and risk factors
Christine Koval, MD ; Mark Orloff, MD ; Anupama Raghuram, MD ; Saman Safadjou, MD

12:30 PM

412

Does the Combination of Lipid Formulation of Amphotericin B (L-AmB) and Echinocandins (ECH) Improve the Outcome of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP)?
Anne-Marie Chaftari, MD ; Ray Hachem, MD ; Christelle Kassis, MD ; Dimitrios Kontoyiannis, MD, ScD, FIDSA ; Coralia Mihu, MD ; Issam Raad, MD ; Elizabeth Ramos, MD

12:30 PM

413

Outcome Analysis of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP) Receiving Salvage Antifungal Therapy: The Role of Novel Azoles
Ray Hachem, MD ; Ying Jiang, MS ; Christelle Kassis, MD ; Issam Raad, MD ; Elizabeth Ramos, MD

12:30 PM

414

Voriconazole Prophylaxis and Mortality in Patients with Acute Myelogenous Leukemia
Sally Alrabaa, MD ; David Atrubin, MPH ; M. Caire, BS ; John Greene, MD ; Richard Oehler, MD ; Tran Phung, MD ; Albert Vincent, PhD ; Gene Wetzstein, PharmD

12:30 PM

415

Feasibility of Aerolized Amphotericin B Lipid Complex (ae-ABLC) Therapy in Cancer Patients with Pulmonary Fungal Infections
Vijayashri Rallapalli, MD ; Gilhen Rodriguez, MD ; Amar Safdar, MD

12:30 PM

416

Comparison of Levofloxacin (L) versus Levofloxacin plus Doxycyline (L-D) for Febrile Neutropenia (FN) Antibiotic (Abx) Prophylaxis (Px) in Patients Undergoing Autologous Hematopoietic Stem Cell Transplants (aHSCT)
Robert Bradbury, R Ph, MA ; Donn Davis, PharmD ; Hugo Fernandez, MD ; John Greene, MD ; Rod Quilitz, PharmD, BCOP

12:30 PM

417

Combination Therapy vs. Monotherapy for the Treatment of Nosocomial Clostridium difficile Infection (CDI)
Noreen Chan Tompkins, PharmD ; Cheryl Herbert, RN, CIC ; Molly McGraw, PharmD ; Andrew Sahud, MD

12:30 PM

418

Factors Predictive for Severe Clostridium difficile infection (CDI) in the Elderly - A Case-Control Study
George Alangaden, MD ; Teena Chopra, MD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Jasdeepa Nagi, MD

12:30 PM

419

Using Automated Data for Objective and Consistent Definition and Case Identification of Nosocomial Clostridium difficile Infections (NCDI)
Stephen Brossette, MD, PhD ; Christine Huizinga, MPH ; Xiaowu Sun, PhD ; Ying Tabak, PhD ; Daisy Wong, PhD

12:30 PM

420

Age, Serum Albumin, and Leukocytosis/Fever Predict Clinical Outcomes of Clostridium difficile Infection Treated with Fidaxomicin and Vancomycin
Y Golan, MD ; A Lentnek, MD ; T Louie, MD ; M Miller, MD ; K Mullane, DO ; Pam Sears, PhD ; Y-K Shue, PhD ; Karl Weiss, MD

12:30 PM

421

The Impact of ICD-9-CM Code Rank-Order on the Estimated Prevalence of Clostridium difficile Infection
Anne Butler, MS ; Erik Dubberke, MD, MSPh ; Victoria Fraser, MD ; Yosef Khan, MBBS, MPH ; Julie Mangino, MD ; Jeanmarie Mayer, MD ; L. Clifford McDonald, MD

12:30 PM

422

Faster Time to Resolution of Diarrhea with Fidaxomicin vs. Vancomycin in Patients with Clostridium difficile Infection
Y Golan, MD ; A Lentnek, MD ; T Louie, MD ; M Miller, MD ; K Mullane, DO ; Pam Sears, PhD ; Y-K Shue, PhD ; Karl Weiss, MD

12:30 PM

423

Compliance with Institutional Guidelines Improves Outcomes of C.difficile Infection (CDI)
Rachel Chambers, PharmD ; Susan L Davis, PharmD ; Laura Johnson, MD ; Chad Richardson, PharmD ; Marcus Zervos, MD

12:30 PM

424

What is the Clinical Significance of C. difficile Antigen Positive, 2-Step Toxin Negative Stools?
James Bondi, MS ; Amy Chang, MD ; Susan DiRenzo, MS ; Ignacio Echenique, MD ; Phyllis Flomenberg, MD ; Donald Jungkind, PhD ; John Passick, MS

12:30 PM

425

Does Electronic Clostridium difficile-Associated Disease (CDAD) Surveillance Underestimate Disease Burden?
J Como, MD ; Bala Hota, MD ; I Oana, MD ; K Popovich, MD ; R Weinstein, MD

12:30 PM

426

Oral vancomycin 6-week taper regimen, as treatment for both initial and recurrent disease, reduces relapse of Clostridium difficile infection (CDI)
Vi Le, PharmD ; Corinne Lieu, BS ; Dale Lieu, MD ; Anne Nguyen, PharmD ; Leia Skol, PharmD

12:30 PM

427

Clostridium difficile Infection (CDI), Mortality, and Hospital Utilization after Hematopoietic Stem Cell Transplantation (HSCT)
C Bertozzi-Villa, Undergraduate ; K Mullane, DO ; D Pitrak, MD ; Kenneth Pursell, MD ; C Ramaprasad, MD, MPH ; K Van Besien, MD ; Stephen G. Weber, MD, MS

12:30 PM

428

Asymptomatic Clostridium Difficile Colonization among Hospitalized Patients at a Tertiary Care Center
Kimberly Aronhalt, MA, BSN, RN ; Surbhi Leekha, MBBS, MPH ; Robert Orenstein, DO ; Robin Patel, MD, FIDSA ; Jon Rosenblatt, MD ; Mary Shelerud, RN, BSN ; Martha Siska, RN, BSN ; Lynne Sloan, BS

12:30 PM

429

Rapidly Fatal Clostridium difficile Infections in the Elderly: A Report of 38 Cases
William Cohee, PharmD ; Andrea Fountain, BA ; Clinton Merritt, MD ; Carolyn Palmer, BSN ; Cirle Warren, MD

12:30 PM

430

Clostridium difficile Infection (CDI) in Cancer Pts: A Case-Control Study
Javier Adachi, MD ; Roy Chemaly, MD, MPH ; Herbert DuPont, MD, FIDSA ; Ray Hachem, MD ; Issam Raad, MD ; Dhanesh Rathod, MD ; Jharna Shah, MD ; Karen Vigil, MD

12:30 PM

431

Abdominal CT Findings Predict Serious Complications from C difficile Infection
Frank Friendenberg, MD, MS (epi) ; Deepa Gujja, MD ; Sabba Maqbool, MD

12:30 PM

432

A Near-Real-Time Method for Discovering Healthcare Worker Social Networks via Wireless Devices
Donald Curtis, MCS ; Jason Fries, BS ; Ted Herman, PhD ; Christopher Hlady, BS ; Sriram Pemmaraju, PhD ; Philip M. Polgreen, MD ; Alberto Segre, PhD ; Monica Severson, BA

12:30 PM

433

Use of Web-Based Influenza Surveillance System for Seasonal and Novel (H1N1) Influenza Activity
David Blythe, MD, MPH ; Rene Najera, MT, MPH ; Dale Rohn, MPH ; Lucy Wilson, MD

12:30 PM

434

A Free iPhone Application for Recording Hand Hygiene Rates
Donald Curtis, MCS ; Jason Fries, BS ; Ted Herman, PhD ; Christopher Hlady, BS ; Sriram Pemmaraju, PhD ; Philip M. Polgreen, MD ; Alberto Segre, PhD ; Monica Severson, BA

12:30 PM

435

The Use of Twitter to Track Public Concerns about Novel H1N1 Influenza
Philip M. Polgreen, MD ; Alberto Segre, PhD ; Alessio Signorini, MCS

12:30 PM

436

Effective Use of Popular Internet Video Broadcast Site Youtube for Dissemination of Information About the Potential Pandemic of H1N1 Influenza
Ambarish Pandey, MBBS ; Nivedita Patni, MBBS ; Mansher Singh, MBBS

12:30 PM

437

Studying Emerging Infections in Social Networks of Patients and Healthcare Workers in Emergency Departments
Jose Benuzillo, MA, MS ; Richard N Greenberg, MD ; Adi Gundlapalli, MD, PhD, MS ; Joseph Hales, PhD ; Molly Leecaster, PhD ; Xiulian Ma, M Stat ; Warren Pettey, MPH, CPH ; Matthew Samore, MD, FSHEA

12:30 PM

438

Clinical outcome of catheter-salvage in neutropenic cancer patients with catheter-related infection
Doo Ryeon Chung, MD ; Eun Jeong Joo, MD ; Cheol-In Kang, MD, PhD ; Joung A Lee, MD ; Kyong Ran Peck, MD, PhD ; Jae-Hoon Song, MD

12:30 PM

439

Clinical outcome and risk factors for mortality in low-risk febrile neutropenic cancer patients
Doo Ryeon Chung, MD ; Young Eun Ha, MD ; Eun-Jeong Joo, MD ; Mi-kyong Joung, MD ; Cheol-In Kang, MD ; Jeong-a Lee, MD ; Soo-youn Moon, MD, fellow ; Kyong Ran Peck, MD ; Kyung Mok Sohn, MD, fellow ; Jae-Hoon Song, MD

12:30 PM

440

Epidemiologic Study of the Spectrum of Bloodstream Infections (BSIs) in Acute Myeloid Leukemia (AML) Patients Over an Eight-Year Period
Tim George, PharmD ; John Greene, MD ; K. Leigh McFarland, PharmD ; Rod Quiltz, PharmD, BCOP ; Dawn Ruge, BS ; Ramon Sandin, MD ; Gene Wetzstein, PharmD

12:30 PM

441

Clinical Characteristics and Virulence Factors of Escherichia coli Infections in Cancer Patients
Javier Adachi, MD ; Nadim Ajami, BS ; Herbert DuPont, MD, FIDSA ; Zhi-Dong Jiang, MD, PhD ; James Johnson, PharmD ; Brian Johnston, PhD ; Issam Raad, MD ; Jeffrey Tarrand, MD ; Karen Vigil, MD

12:30 PM

442

Infectious Complications in Patients Treated with Dasatinib
Saud Ahmed, MD ; Fadi Al Akhrass, MD ; Vijayashri Rallapalli, MD ; Gilhen Rodriguez, MD ; Amar Safdar, MD

12:30 PM

443

Multiple Granulocyte Transfusions for the treatment of severe opportunistic infections in cancer patients - 2004 - 2007
Saud Ahmed, MD ; Shamin Ejaz, MD ; Gilhen Rodriguez, MD ; Amar Safdar, MD

12:30 PM

444

Predictors of Catheter Related Gram Negative Bacteremia (CR-GNB) in Cancer Patients
Javier Cairo, MD, MPH ; Bruno Granwehr, MD ; Ray Hachem, MD ; Issam Raad, MD ; Gopikishan Rangaraj, MD

12:30 PM

445

Bloodstream Infection Rates and Costs Associated with Compounded versus Multi-Chamber Bag Parenteral Nutrition in Oncology
Matthew Reynolds, PhD ; Victor Rosenthal, MD ; Shane Scott, PharmD ; Robin Turpin, PhD ; Katie Williams, MPH

12:30 PM

446

Percutaneous Endoscopic Gastrostomy (PEG) Tube Site Infections in Cancer Patients
John Greene, MD ; Sreenath Kodali, MD ; Stacy Martin, RN ; Kathie McDonald, RN ; Kay Sams, RN

12:30 PM

447

Citrobacter Bacteremia in Patients with Solid Tumor Patients at a Tertiary Care Cancer Center in Japan
Takahiro Fujita, MD ; Yoshiaki Gu, MD ; Naoki Kishida, MD ; Norio Ohmagari, MD ; Keiji Okinaka, MD ; Tomoaki Sato, Medical Technologist

12:30 PM

448

Extraintestinal Pathogenic Escherichia coli (ExPEC) Pneumonia in Cancer Patients
Javier Adachi, MD ; Nadim Ajami, BS ; Herbert DuPont, MD, FIDSA ; Zhi-Dong Jiang, MD, PhD ; Jeffrey Tarrand, MD ; Karen Vigil, MD

12:30 PM

449

Neutropenic Enterocolitis Complicating Taxane Based Antineoplastic Chemotherapy
Kenneth Rolston, MD

12:30 PM

450

Downstream Effects of an Intensive Care Unit Antibiotic Stewardship Intervention on Hospital-Wide Antibiotic Utilization
Deborah Anderson, PharmD ; William Burman, MD ; Ivor Douglas, MD ; Timothy Jenkins, MD ; Philip Mehler, MD ; Connie Price, MD ; Allison Sabel, MD, PhD, MPH ; Amy Trantanella, BS

12:30 PM

451

Effect of the Addition of Post-Prescription Analysis (PPA) to a Prior Approval (PA) Antimicrobial Stewardship Program (ASP) on Time to Optimal Antimicrobial Therapy in a University Hospital
Shawn Binkley, PharmD ; Neil Fishman, MD ; Leanne Gasink, MD ; Amanda Hurst, PharmD ; Kara Mascitti, MD ; Steven Morgan, PharmD

12:30 PM

452

A Stepwise Approach to Antimicrobial Stewardship- Good for Prescribing and Fellows
Philip Chung, PharmD ; Yi Guo, PharmD ; Ira Leviton, MD ; Belinda Ostrowsky, MD, MPH

12:30 PM

453

Can an Individualized Educational Stewardship Program Affect Prescribing Patterns and Reduce Antimicrobial Resistance?
Joseph Alessandrini, BSPharm ; John Gums, PharmD, FCCP ; David Kaufman, MD ; Vivien Ng, BSPharm ; Steven Smith, PharmD

12:30 PM

454

Antimicrobial Stewardship Program (ASP): Five Year Evaluation of Interventions and Outcomes at a Pediatric Teaching Hospital
Shannon Chan, Pharm D ; M. Cecilia Di Pentima, MD, MPH

12:30 PM

455

Prior Authorization Encounters for Restricted Drugs in an Established Antimicrobial Stewardship Program
James Beardsley, PharmD ; Jesse Couk, MD ; James Johnson, PharmD ; Vera Luther, MD ; Christopher Ohl, MD ; John Williamson, PharmD

12:30 PM

456

The Effects of an Electronically Enhanced Antimicrobial Stewardship Program in Two Critical Care Locations at a 415 Bed Urban Hospital
Stephen Brossette, MD, PhD ; Emily Falk, MSPH ; Kyoung Sil Kim, PharmD ; Peter Lao, MS RPh ; Frank Palmieri, PhD, RPh ; Larry Schiller, RPh ; Prashant Tayshetye, MD, MPH

12:30 PM

457

Utility of Computerized Surveillance of Antibiotic Resistance and Usage in an Antimicrobial Stewardship Program
Brenda Ang, MBBS, M Med, MPH, FAMS ; Prabha Krishnan, MBBS, MRC Path, DTM&H, FRC Path ; Yee-Sin Leo, MBBS ; Wan-Peng Lim, BS ; David Lye, MBBS ; Tat-Ming Ng, BS ; Christine Teng, MS

12:30 PM

458

Evaluation of Antimicrobial Stewardship Models in the Intensive Care Unit: Impact on Antimicrobial Selection and Emergence of Resistance
Carlos DiazGranados, MD, MS

12:30 PM

459

Impact of Antibiotics Stewardship Program on Appropriateness of Fluoroquinolone Use at a Community Hospital
Kalil Al-Nassir, MD ; Kell Julliard, MA ; Rama Krishna Mukkara Siva, MD ; Afaf Pouls, MD ; Nadeem Shahid, MD ; Rohit Sharma, MD ; Surinder Singh, MD ; Taleb Taha, MD ; David Tompkins, MD ; Ernest Visconti, MD

12:30 PM

460

Shut Off Vancomycin Early (SHOVE) Program
Graeme Forrest, MBBS ; Nathan Johnson, Pharm D ; Heather Norvelle, PharmD ; Jessica Steffl, Pharm D ; Jerusha Taylor, Pharm D

12:30 PM

461

Risk Factors for Inappropriate Initial Empiric Therapy (IET) in Hospitalized Patients with Skin & Soft Tissue Infection (SSTI)
Katherine Freeman, DrPH ; Myoung Kim, PhD ; Katherine Miracola, BS ; Lien Vo, PharmD ; Marcos Zervos, PhD

12:30 PM

462

Emergency Department Visits of Patients on Community-based Parenteral Anti-infective Therapy at Home
Steven Gordon, MD, FIDSA ; Anil Jain, MD ; Steven Landers, MD, MPH ; Divya Patel, DO ; Susan Rehm, MD ; Nabin Shrestha, MD

12:30 PM

463

Infectious Diseases (ID) Consultation Decreases the Readmission Rate of Patients Receiving Outpatient Parenteral Antibiotic Therapy (OPAT)
Jose Cadena, MD ; Kelly Echeverria, PharmD ; Wayne Fischer, BS, MS, PhD ; Tony Ho, MD ; Amruta Parekh, MD, MPH ; Jan E. Patterson, MD, FIDSA, FSHEA

12:30 PM

464

Safety and Efficacy of Direct Physician-Operated Infusion Center (POIC) Admissions for Antibiotic Treatment of Osteomyelitis (OSTEO) and Complicated Skin and Skin Structure Infections (cSSSI)
Richard Prokesch, MD ; Maureen Strong, PharmD ; Lucinda Van Anglen, PharmD

12:30 PM

465

Antimicrobial Use in Ambulatory Patients on Warfarin
Scott Devine, PhD ; Michael Lane, MD, MSc ; Jay McDonald, MD

12:30 PM

466

Mortality Associated with Staphylococcus aureus Bacteremia; The Value of Infectious Diseases Consultation
Peter Brookmeyer, MD ; Hitoshi Honda, MD ; Jeffrey Jones, MD ; Melissa Krauss, MPH ; David K. Warren, MD, MPH

12:30 PM

467

Outcome of MRSA Bacteremia in Cancer Patients Treated with Vancomycin
Javier Adachi, MD ; Roy Chemaly, MD, MPH ; Ray Hachem, MD ; Victor Mulanovich, MD ; Issam Raad, MD ; Dhanesh Rathod, MD ; Jharna Shah, MD

12:30 PM

468

Evolution of in vitro susceptibility of Staphylococcus aureus (SA) blood isolates at a university hospital
Alexandra Sonyey, MD ; Melvin Weinstein, MD

12:30 PM

469

Vancomycin Minimum Inhibitory Concentrations (MICs) of Methicillin Resistant Staphylococcus aureus (MRSA) Isolates in a Community Hospital Setting as Measured by E-test Vs Automated Reporting
Paul Carson, MD ; Avish Nagpal, MD ; Robert Nelson, PharmD ; William Newman, MD ; Loren Podoll, PharmD ; Jody Thompson, MD

12:30 PM

470

Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia (SAB) in Hemodialysis (HD): Trends Over 13 Years
Leonard Johnson, MD ; Riad Khatib, MD ; Karam Obeid, MD ; Kathleen Riederer, BS, MT ; Stephen Shemes, BS ; Anilrudh Venugopal, MD

12:30 PM

471

Community- and Healthcare-associated Staphylococcus aureus in an Integrated Healthcare Network in Salt Lake City, UT, 2001-2008: Is the Epidemic Abating?
John Burke, MD ; Toru Kamiya, MD ; Rajesh Mehta, RPh, MS ; David Pombo, MD

12:30 PM

472

Effect of Methicillin-Resistant Staphylococcus aureus (MRSA) Targeted Interventions on Non-MRSA Multidrug-Resistant Organisms (MDROs)
F Arnold, DO ; D Borton, BSN, RN, CIC ; P Chang, MPH ; Katherine Ellingson, PhD ; L Goss, MSN, RN, CIC ; N Iverson, BSN, RN, CIC ; J Jernigan, MD, MS ; Alexander Kallen, MD, MPH, FSHEA ; C Lindberg, DMan ; J Lloyd, MD ; J Stelling, MD, MPH ; J Zuckerman, MD

12:30 PM

473

Staphylococcus aureus Bloodstream Infection: A Two-year Study of Outcomes
Sevag Balikian, MD ; Bahareh Ghafarizadeh, M.D. ; Arash Heidari, M.D. ; Royce Johnson, MD

12:30 PM

474

Evaluation of MRSA Burden Using Administrative Data and Microbiology Lab Results
R Evans, PhD ; Rachel Gorwitz, MD, MPH ; Michael A. Jhung, MD, MPH ; James Lloyd, BS ; Michael Mundorff, MBA/MHSA ; Pat Nechodom, MPH ; Matthew Samore, MD, FSHEA

12:30 PM

475

The Prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Colonization Among Health Care Workers (HCW) at an Urban Hospital
Henry Fraimow, MD ; Christopher Knob, BS ; Florence Momplaisir, MD ; Annette Reboli, MD

12:30 PM

476

Impact of USA300 Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Clinical Outcomes
Sandra Bulens, MPH ; Ghinwa Dumyati, MD ; Gregory Fosheim, MPH ; Scott Fridkin, MD ; Kenneth Gershman, MD ; Fernanda Lessa, MD ; Ruth Lynfield, MD ; Yi Mu, PhD ; Joelle Nadle, MPH ; Wayne Ray, PhD ; William Schaffner, MD

12:30 PM

477

Using a Point Prevalence Survey (PPS) to Estimate Incidence of Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization Among Intensive Care Unit (ICU) Patients (pts) Across a Region
for the CDC Prevention Epicenters Program ; Mary Hayden, MD, FSHEA ; Michael Lin, MD, MPH ; Karen Lolans, BS ; Rosie Lyles, MD, MHA ; William Trick, MD ; Stephen G. Weber, MD, MS ; Robert Weinstein, MD, FIDSA

12:30 PM

478

Vancomycin MICs, Heteroresistance, Clinical Features and Mortality for Hospitalized Patients with Persistent and Non-Persistent MRSA Bacteremia
Frederick Abrokwah, MD ; John M. Boyce, MD, FIDSA ; Nancy L. Havill, MT(ASCP), CIC ; Michael Virata, MD

12:30 PM

479

A Study of the Relationship Between MRSA Colonization and Acquisition of Infection with the Similar or Different Strains
Donna Armellino, RN ; Dazhi Chen, MD ; Bruce Farber, MD ; Taynet Febles, MD ; Christine Ginocchio, PhD ; Diamanto Korologos, Masters Degree ; Barry Kreiswirth, PhD ; Jose Mediavilla, BS ; Nancy Musa, RN ; Mary Ellen Schilling, RN ; Frank Zhang, MD

12:30 PM

480

Acquisition and Infection Caused by Methicillin-resistant Staphylococcus aureus [MRSA]: A Comparison of Long Term Care Wards [LTCW] before and after Reduction of Isolation Procedures in a U.S. Veterans Affairs Medical Center [VAMC]
Kent Crossley, MD ; Stephen Ewing, MD ; Tina Scott, RN ; Joseph Thurn, MD, MPH

12:30 PM

481

Long-Term Outcome of Patients with Nosocomially Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization
Gio Baracco, MD ; Nathaniel Duke, MD

12:30 PM

482

Ongoing Multi-clonal Dissemination of Methicillin Resistant Staphylococcus aureus (MRSA) Soft Tissue Infections in A Veterans' Long Term Care Facility (LTCF)
G.V. "Sonny" Montgomery MRSA Team ; Rathel Nolan III, MD ; Chere Peel, MD ; Donna Sullivan, PhD ; Risa Webb, MD, DTMH ; Gail Woods, PhD

12:30 PM

483

Results of an Outbreak Investigation of MRSA Colonization in MICU Patients
Susan Blake, RN, MBA, OCN ; Lorre Coates, RN, BSN ; Janice Lattus, RN, MPH, CIC ; Raul Nakamatsu, MD ; Paula Peyrani, MD ; Julio Ramirez, MD ; Joanna Sarver, RN, BSN ; Carmen Sciortino, PhD

12:30 PM

484

Stratified analysis of sources of MRSA bacteraemia to inform intervention strategy in the English National Health Service
Andrew Pearson, MD

12:30 PM

485

Molecular Characterization of Nosocomial Transmission of Methicillin Resistant Staphylococcus aureus in a Veterans Affairs Medical Center (VAMC)
Kyle Breitschwerdt, BS ; Sara Hoffman, BSN ; Daphne Jones, BS ; Maria Joyce, MD ; Brad Nicholson, PhD ; Lawrence Park, PhD ; Susan Wilkins, BS, MDiv ; Christopher Woods, MD, MPH

12:30 PM

486

Active Surveillance for MRSA in Hospitalized Patients: Impact on Colonization and Bacteremia
Susan Blake, RN, MBA, OCN ; Lorre Coates, RN, BSN ; Janice Lattus, RN, MPH, CIC ; Raul Nakamatsu, MD ; Paula Peyrani, MD ; Joanna Sarver, RN, BSN ; Carmen Sciortino, PhD ; Timothy Wiemken, MPH

12:30 PM

487

MRSA Surgical Site Infections - What Is the Role of SCCmec Type IV Community-Associated Strains?
Phyllis Flomenberg, MD ; James Harrop, MD ; Donald Jungkind, PhD ; Mitchell Maltenfort, PhD ; Dionissios Neofytos, MD ; Shilpa Rao, MD ; Gustavo Vasquez, MD

12:30 PM

488

Is PCR Better Than Culture For MRSA Surveillance in the ICU?
Lisa Bailey, RN, MS, BSN ; Victor Jimenez, MD ; Michael Shulman, MS ; Shantala Subramanyam, MD

12:30 PM

489

Does Rapid Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization upon Admission Modify the Duration of Empiric Vancomycin Use in the Medical Intensive Care Unit (MICU)?
Molly Billstein, PharmD ; William Loeffler, PharmD ; Erica Tenholder, PharmD ; Jeffrey Topal, MD ; Jessica Vital, PharmD

12:30 PM

490

An Outbreak Investigation: Methicillin-sensitive Staphylococcus aureus (MSSA) surgical site infection after spinal surgery
Dong Lee, MD ; Ole Vielemeyer, MD

12:30 PM

491

Methicillin-Susceptible Staphylococcus aureus Infections After Intra-Articular Injections
W. Roodly Archer, PhD ; Matthew Arduino, MS, DrPH ; Kathryn Arnold, MD ; Heidi Davidson, MPH ; Cherie Drenzek, MS, DVM ; Gregory Fosheim, MPH ; Bette Jensen, MMSc ; Sigrid McAllister, BS, MT(ASCP) ; Judith Noble-Wang, PhD ; Joseph Perz, DrPH ; Ariane Reeves, RN, BSN, MPH, CIC ; Melissa Schaefer, MD ; Arjun Srinivasan, MD

12:30 PM

492

Impact of Education on Drug Utilization- One Year Experience in Two Community Hospitals with a Mandatory Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Program
Bhavna Desai, MT ; Diana Finkel, DO ; Kevin McDonough, BS, PharmD , MPA ; Aldyth Stanford, RN

12:30 PM

493

Linezolid vs. Vancomycin: Re-hospitalization Rates among Patients with Pneumonia, Staphylococcal Infection, and Skin and Soft Tissue Infection
Catherine Cooke, PharmD ; Van Doren Hsu, PharmD ; C. Daniel Mullins, PhD ; Eli Perencevich, MD, MS, FIDSA, FSHEA ; Ahmed Shelbaya, MD, MPH, MSc ; Anna Wallace, MPH

12:30 PM

494

Sustained reduction in MRSA surgical site infections (SSI) following Cardiothoracic (CT) Surgery
Linda Greene, RN ; Ronald Kirshner, MD ; Edward Walsh, MD, FIDSA

12:30 PM

495

High Prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) Nasal Carriage among TB Patients at a Rural Hospital in South Africa
Kathryn Catterick, RN, ICM ; Gerald Friedland, MD, FIDSA ; Scott Heysell, MD, MPH ; Sheela Shenoi, MD, MPH ; Tania Thomas, MD, MPH

12:30 PM

496

B Lactam Therapy is Superior to Vancomycin for Staphylococcus lugdunensis Prosthetic Joint Infections
Neel Shah, MD

12:30 PM

497

Scoring System for the Prediction of Vancomycin-Resistant enterococci Pre-colonization at Admission to Intensive Care Unit
Hee Jin Cheong, MD ; Won Suk Choi, MD ; Jung Yeon Heo, MD ; Yu Mi Jo, MD ; Woo Joo Kim, MD ; Ji Yun Noh, MD ; Joon Young Song, MD

12:30 PM

498

Management of a Regional Outbreak of VanA Vancomycin-Resistant Enterococcus faecium (VRE) Colonization
Vincent Gendrin, MD ; Sandrine Henard, MD ; Nathalie Jouzeau, Nurse ; Christian Rabaud, MD, PhD ; Loic Simon, PharmD ; Nathalie Vernier, Nurse

12:30 PM

499

Treatment of Enterococcal Bloodstream Infection (BSI) with Linezolid
Rachel Chambers, PharmD ; Susan L Davis, PharmD ; Jeff Hurren, PharmD ; Lindsay Lessl, PharmD Candidate ; Jason Watt, PharmD Candidate ; Marcus Zervos, MD

12:30 PM

500

Surveillance for hospital-acquired VRE and MRPA infections using electronic algorithms
Makoto Jones, MD, MS ; Patricia Nechodom, MPH ; Michael Rubin, MD, PhD ; Matthew Samore, MD, FSHEA

12:30 PM

501

Evaluation of the Duration of VanA Vancomycin-Resistant Enterococcus faecium (VRE) Carriage in Stools during a Large-Scale Outbreak Occurring in a Region of the Eastern Part of France
Nejla Aissa, MD ; Sandrine Henard, MD ; Nathalie Jouzeau, Nurse ; Alain Lozniewski, MD, PhD ; Christian Rabaud, MD, PhD

12:30 PM

502

Epidemiology and Outcomes of Enterococcal Infective Endocarditis (EIE)
Rachel Chambers, PharmD ; Susan L Davis, PharmD ; Jeff Hurren, PharmD ; Lindsay Lessl, PharmD Candidate ; Jason Watt, PharmD Candidate ; Marcus Zervos, MD

12:30 PM

503

Lack of Impact of Multi-drug Resistant Organism Screening and Isolation on Hospital Acquired Infections
Jane M. Gould, MD ; Patricia Hennessey, MSN ; Andrea Kiernan, AAS ; Tamara Stein, MD ; Sheila Wood, PhD

12:30 PM

504

Multidrug Resistant Acinetobacter Infections: Treatment and Patient Outcomes
Janine Douglass, MPH ; Ameet Hingwe, MD ; Laura Johnson, MD ; Sophia Mehboob, MD ; Marcus Zervos, MD

12:30 PM

505

Transition of Antimicrobial Susceptibilities of Nosocomial Acinetobacter baumannii Meningitis
Misuk Lee, MD, PhD ; Song Mi Moon, MD

12:30 PM

506

Multidrug Resistant Acinetobacter - A Persistent Threat
Janine Douglass, MPH ; Ameet Hingwe, MD ; Laura Johnson, MD ; Sophia Mehboob, MD ; Marcus Zervos, MD

12:30 PM

507

Carbapenem-resistant Klebsiella pneumoniae in Emory University Affiliated Hospitals,
2006 - 2008
Eileen Burd, PhD, D(ABMM) ; William Flanders, MD, DSc ; Ketevan Kobaidze, MD, PhD ; David Kuhar, MD ; Kenneth Leeper, MD, FCCP ; Cindy McCloskey, MD ; Bruce Ribner, MD, MPH ; James Steinberg, MD

12:30 PM

508

Successful Limb-Sparing Treatment Strategy for Diabetic Foot Osteomyelitis
Alison Beieler, PA-C ; Robert Belknap, MD ; Merribeth Bruntz, DPM ; Timothy Jenkins, MD ; Connie Price, MD ; Carla Saveli, MD

12:30 PM

509

Wound Infection Surveillance of War Wounds in British Forces Personnel
Andrew Green, MD ; Deborah Mortiboy, MD ; Tania Thomas, RGN, MSc

12:30 PM

510

The accuracy of a diagnosis of “cellulitis” among hospitalized patients
Sandy Chira, BS ; Noah Craft, MD, PhD, DTM&H ; Consuelo David, BA ; Samantha Eells, MPH ; Manasi Ladrigan, MD ; Loren Miller, MD, MPH ; Art Papier, MD

12:30 PM

511

Infections associated with cardiac rhythm management device replacement: Results from the REPLACE Registry
Richard Borge, MD ; Mina Chung, MD ; Dan Dan, MD ; Marye Gleva, MD ; Venkateshwar Gottipaty, MD ; Richard Holcomb, PhD ; Theofanie Mela, MD ; Jeanne Poole, MD ; Timothy Shinn, MD ; Daniel Uslan, MD ; David Warren, MD, MPH

12:30 PM

512

Healthcare-Associated Infections in Vietnam, 2007: Epidemiology and Risk Factors
Truong Anh Thu, MD, MPH ; Lennox Archibald, MD, PhD ; Pham Duc Muc, MD, MPH ; Nguyen Ngo Quang, MD, MPH ; Li Thi Thanh Thuy, MD ; Nguyen Viet Hung, MD, PhD

12:30 PM

513

Targeted MDRO Screening in a Children's Hospital Shows High Rate of Colonization
Jane M. Gould, MD ; Patricia Hennessey, MSN ; Andrea Kiernan, AAS ; Sarah Long, MD ; Sheila Wood, PhD

12:30 PM

514

Risk Factors for Acquisition of Trimethoprim-sulfamethoxazole Resistant Stenotrophomonas maltophilia: A Case-Control Study
Doo Ryun Chung, MD PhD ; Mi-kyong Joung, MD ; Cheol-In Kang, MD ; Jeong-a Lee, MD ; NamYong Lee, MD PhD ; Soo-youn Moon, MD, fellow ; Kyong Ran Peck, MD, PhD ; Kyung Mok Sohn, MD, fellow ; Jae-Hoon Song, MD

12:30 PM

515

Pseudomonas Infections: Do we really need double coverage? A Systematic Review
Sharon alroy-Preis, MD ; Nadine McLeod, Ms

12:30 PM

516

Screening Nursing Home Residents on Admission for MDROs: Is it worth it?
Phyllis Andrews, RPA-C ; Christina Coyle, MD ; Dimitrios Farmakiotis, MD

12:30 PM

517

Prevalence of Multi-Drug Resistant Organisms (MDRO) in Patients Admitted From Long Term Care Facilities (LTCF)
Rekha Murthy, MD ; Tuan Ta, MD

12:30 PM

518

Changing Incidence of Multidrug-Resistant Organisms Isolated in a Military Medical Center
Wade Aldous, PhD ; Edward Keen, PhD ; Clinton K. Murray, MD ; Brian Robinson, MS

12:30 PM

519

Higher than Expected Annual QuantiFERON-Gold (QFT-G "Conversion" Rate Suggests Need for Redfining Reactivity Criteria in Health Care Workers (HCWs)
Arthur Brown, MD ; Cynthia Eisenstein, RN ; William Schneider, MD, MPH

12:30 PM

520

Poor Reproducibility of Interferon-γ Release Assays For the Diagnosis of Latent TB amongst Healthcare Workers
Niaz Banaei, MD ; Victor Herrera, MD ; Kelly Murphy, MD ; Julie Parsonnet, MD, FIDSA ; Sharon Perry, PhD

12:30 PM

521

Questionable Effectiveness of Quantiferon TB Gold Test as Screening Tool
Michelle Feigenbaum, RN, BSN ; Sumanth Gandra, MPH, MD ; William Scott, MD, MPH ; Vijaya Somaraju, MD, MPH ; Huaping WANG, PhD ; Suzanne Wilton, MS APN, CNP

12:30 PM

522

Severe Influenza Pneumonia Surveillance (SIPS) Project: A Tool for the Detection of Human and Non-human strains of Influenza A in Kentucky
Forest Arnold, DO ; Kristina Bryant, MD ; Patricio Cabral, MD ; Raul Nakamatsu, MD ; Paula Peyrani, MD ; Julio Ramirez, MD ; Carmen Sciortino, PhD ; James Snyder, PhD ; James Summersgill, PhD ; Timothy Wiemken, MPH

12:30 PM

523

Biosurveillance for Influenza-Like Illness in Veterans Affairs Healthcare Facilities during the 2009 Novel H1N1 Outbreak
Mark Holodniy, MD ; Cynthia Lucero, MD ; Gina Oda, MS ; Patricia Schirmer, MD

12:30 PM

524

Choice of Test for Influenza-like Illness is Heavily Influenced by Physician Specialty and Preference
Steven Gordon, MD, FIDSA ; Anil Jain, MD ; Nikole Scalera, MD, MS ; Nabin Shrestha, MD ; Belinda Yen-Lieberman, Ph.D.

12:30 PM

525

Screening for Novel H1N1 at a Tertiary Health System in Texas
Jose Cadena, MD ; Patti Grota, PhD, RN, CIC ; Jan E. Patterson, MD, FIDSA, FSHEA ; Thomas Patterson, MD, FIDSA

12:30 PM

526

Evaluation of Healthcare Personnel Exposed to Inpatients with Novel Influenza A (H1N1) _ Texas, April - May 2009
Tracy Ayers, MS ; Fatimah Dawood, MD ; Lyn Finelli, DrPH, MS ; Vincent Fonseca, MD ; George Han, MD ; Kathy Hancock, PhD ; Alexander Kallen, MD, MPH, FSHEA ; Jacqueline Katz, PhD ; Kai-Wood Ma, MD, MPH ; Manoj Menon, MD, MPH ; Sonja Olsen, PhD

12:30 PM

527

The Effect of Rates of Staff Influenza Vaccination and Reporting Time of Influenza Outbreaks on the Duration of Nursing Home Influenza Outbreaks in Maryland
David Blythe, MD, MPH ; Alvina Chu, MHS ; Shawn Kiernan, MPH ; Brenda Roup, PhD, RN ; Lucy Wilson, MD

12:30 PM

528

Knowledge, Attitudes and Poultry-Handling Practices of Poultry Workers in Relation to Avian Influenza in India
Prashanth Alle, MBBS ; Kumar Belani, MBBS, MS ; Bobby Joseph, MD, DNB ; Sudhir Kumar, MD ; Michael Osterholm, PhD, MPH ; Naveen Ramesh, MD, DIH ; Srinand Sreevatsan, DVM, PhD, MPH

12:30 PM

529

Experience with Seasonal Zanamivir Prophylaxis in Canadian Healthcare Workers and Other Adults: A Pilot Study
Bjug Borgundvaag, MD ; Brenda Coleman, PhD ; Steven Drews, PhD ; Karen Green, MSc ; Jeffrey Kwong, MD ; Joanne M. Langley, MD, FSHEA ; Mark Loeb, MD, MSc ; Donald Low, MD ; Allison McGeer, MD, FRCPC ; Shelly McNeil, MD ; Christine Moore, BSc ; Matthew Muller, MD, PhD ; Andrew E. Simor, MD, FRCPC ; Danuta Skowronski, MD ; STOP-Flu Study Group ; Leslie Vincent, MScN

12:30 PM

530

The CDC rules that associate urinary catheter use with urinary tract infection fail to measure what we want
David Ansell, MD, MPH ; Raj Behal, MD, MPH ; Brian Harting, MD ; Tricia Johnson, PhD ; Robert McNutt, MD ; Richard Odwazny, MS ; Caroline Thurlow, MD

12:30 PM

531

A Simple Intervention to Achieve Appropriate Urinary Catheter Use in a University-Affiliated Community Hospital
Jackrapong Bruminhent, MD ; Marjorie Keegan, RN ; Joanne Passalacqua, MD

12:30 PM

532

Potential for misclassification of nosocomial urinary events in the neurologic patient population
Charles Frenette, MD ; Marty Teltscher, MD

12:30 PM

533

Coding for Reimbursement: The Under-Estimated Cost of Catheter-Associated Urinary Tract Infections (CA-UTI)
John Burke, MD ; Kristin Dascomb, MD, PhD ; Rajesh Mehta, RPh, MS ; David Pombo, MD

12:30 PM

534

Accuracy of electronic data in estimating the number of inpatients with a urinary catheter
David Ansell, MD, MPH ; Raj Behal, MD, MPH ; Brian Harting, MD ; Tricia Johnson, PhD ; Robert McNutt, MD ; Richard Odwazny, MS

12:30 PM

535

Uropathogen Adherence to Silver- and Nitrofurazone-coated Urinary Catheters
Manuel Cevallos, MD ; Devak Desai, MD ; Barbara W. Trautner, MD, PhD

12:30 PM

536

Escherichia coli infection by inadequate disinfection of a biopsy needle used in transrectal ultrasound guided prostate biopsy
Kyung-Hwa Park, MD

12:30 PM

537

Comparison of Efficacy Between Chlorhexidine and Povidone Iodine as Abdominal Skin Preparation Among Women Undergoing Cesarean Section and Exploratory Laparotomy for Ectopic Pregnancy: A Randomized Trial
Analyn Fallarme, OB-GYN, IDS

12:30 PM

538

Impact of Daily Skin Cleansing of Medical Intensive Care Unit Patients with a 4% chlorhexidine gluconate (Hibiclens®) on the Incidence of Hospital acquired Multidrug Resistant Organisms
Heather Beitz, BS ; Galo Cubillos, MD ; Alan Hartstein, MD ; Daniel H. Kett, MD ; LaToya Lewis-Pierre, RN, MSN ; Ron Motiram, BA, MBA ; Madelaine Tamayo, RN, MSM

12:30 PM

539

Mycobacterium chelonae Infection After Liposuction: Implications for Infection Control Oversight in the Outpatient Setting
Moon Kim, MD, MPH ; Laurene Mascola, MD, MPH

12:30 PM

540

Hospital Outbreak of Burkholderia cenocepacia Infection Associated with Contaminated Chlorhexidine Solutions Prepared by the Hospital Pharmacy
Seung Woo Han, MD ; Chul Lee Je, MD, PhD ; Gun Woo Kim, MD, PhD ; Ki Tae Kwon, MD, PhD ; Do Young Song, MD

12:30 PM

541

Gown Use Does Not Decrease Transmission of Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VRE) if Hand Hygiene Compliance is Suboptimal
Marci Drees, MD, MS ; Eldad Elnekave, MD ; Scott Epstein, MD ; Yoav Golan, MD MS ; John Griffith, PhD ; Stanley Nasraway, MD ; David Snydman, MD, FIDSA ; Padade Vue, MD

12:30 PM

542

Fight the Fomite: A Dedicated Stethoscope Demonstration Project
Ann Adler, RN ; Paul Fey, PhD ; Mark Rupp, MD, FIDSA ; Valerie Smith, RN

12:30 PM

543

Utilization of Isolation Precautions in a Canadian Tertiary Care Centre
Neera Kumar, _ ; Andrew E. Simor, MD, FRCPC ; Victoria Williams, BSc, BASc, MPH, CIC

12:30 PM

544

Observer Effect on Hand Hygiene (HH) Compliance Reporting
Connie Bohlinger, MS, M(ASCP) ; Thomas Chevalier, RN, BSN, CIC ; Teena Chopra, MD ; Sorabh Dhar, MD ; Beth Dziekan, RN, MS, CIC ; Michelle Fitch, BS ; Elaine Flanagan, CIC ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Beth Toftey, MT(ASCP), CIC, MPH

12:30 PM

545

Risk Factors Associated with Poor Hand Hygiene Adherence among Physicians
Juhee Lee, RN ; Seung Soon Lee, M.D. ; SE Jeong Park, RN

12:30 PM

546

The Utility of a Hand Hygiene Intervention in Preventing Healthcare-Associated Infections in Vietnam
Truong Anh Thu, MD, MPH ; Lennox Archibald, MD, PhD ; Tran Quy, MD, PhD ; Le Thi Thanh Thuy, MD ; Vu Van Giang, MD, MPH ; Nguyen Viet Hung, MD, PhD

12:30 PM

547

Effectiveness of Catheter-Associated Bloodstream Infection Bundle Without and With Intensified Hand Hygiene Promotion in A Thai Tertiary Care Center: A 3-Year Study
Anucha Apisarnthanarak, MD ; Victoria Fraser, MD ; Kanokporn Thongphubeth, RN ; David Warren, MD ; Chananart Yuekyen, RN

12:30 PM

548

Are Healthcare Workers in the USA Switching to Hand Sanitizer? A Six-Year Multicenter Trend Analysis
John Govednik, MS ; Maryanne McGuckin, ScEd ; Richard Waterman, PhD

12:30 PM

549

Microbiological Agents Associated With Death in Wounded Service Members During Operations Iraqi And Enduring Freedom
Joel Gaydos, MD ; Joyce Lapa, MD ; Craig Mallak, MD ; Robert Potter, DVM

12:30 PM

550

Meta-analysis (MA) of Mortality in Febrile Neutropenia (FN) Trials Associated with Cefepime Use
P Kim, MD MS ; Sumathi Nambiar, MD MPH ; A Szarfman, MD PhD ; Y Wu, PhD MPH

12:30 PM

551

Impact of Nosocomial Blood Stream Infection (BSI) in the Elderly on Length of Stay and Hospital Cost
Deverick Anderson, MD MPH ; Ting-Yi Chen, MD ; Yong Choi, RN ; Teena Chopra, MD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Kenneth Schmader, MD ; Rick Sloane, MD

12:30 PM

552

Injection Opiate Abuse and Blood Stream Infection in an Aging HIV-infected Veteran Cohort
Mark Delman, MD ; Angelike P. Liappis, MD

12:30 PM

553

Clinical Predictors of Cardiovascular Implantable Electronic Device-related Infective Endocardititis
David Hayes, MD ; Baddour Larry, MD ; Katherine Y. Le, MD, MPH ; Friedman Paul, MD ; Muhammad Sohail, MD ; James Steckelberg, MD, FIDSA ; Wilson Walter, MD

12:30 PM

554

Complications and Intensity of Care of Community-based Parenteral Anti-infective Therapy for Patients with Cardiac Infections
Mitchell Ballin, MD ; Thomas G. Fraser, MD, FSHEA ; Steven Gordon, MD, FIDSA ; Alice Kim, MD ; Jose Navia, MD ; Gosta Pettersson, MD, PhD ; Susan Rehm, MD ; Nabin Shrestha, MD ; Nicholas Smedira, MD ; Christina Stachur, MPH

12:30 PM

555

Outcomes in Patients Following Surgery for Infective Endocarditis: The Contemporay Cleveland Clinic Experience
Tom Fraser, MD ; Steven Gordon, MD, FIDSA ; Alice Kim, MD ; Manesh Manne, MD ; Jose Navia, MD ; Edward Nowicki, MD ; Gosta Pettersson, MD ; Joseph Sabik, MD ; Nabin Shrestha, MD

12:30 PM

556

Hospitalization for Infection in a National Cohort of Veterans with Rheumatoid Arthritis (RA)
Liron Caplan, MD ; Seth A. Eisen, MD, MSc ; Michael Lane, MD, MSc ; Jay McDonald, MD ; Prabha Ranganathan, MD ; Angelique Zeringue, MS

12:30 PM

557

Catheter Removal versus Retention in the Management of Catheter-Associated Enterococcal Bloodstream Infections
Joshua A Doherty, BS ; Victoria Fraser, MD ; Jonas Marschall, MD ; Marilyn Piccirillo, NA ; David K. Warren, MD, MPH

12:30 PM

558

Biofilm Formation on Standard and Novel, Silver Impregnated Intravenous Catheter Access Devices
Rodney Donlan, PhD ; Jesse Jacob, MD ; Elizabeth Perez, BS ; James Steinberg, MD

12:30 PM

559

Risk factors and Outcomes of Gram-negative Cardiac Device Infections
Leonard Johnson, MD ; Jinson Jose, MD ; Riad Khatib, MD ; Susan Szpunar, PhD

12:30 PM

560

Correlation of Fever and Elevated Leukocyte Count with Chest CT Findings of Septic Pulmonary Emboli in Cardiac Device Related Infections
Ella Ariza-Heredia, MD ; Roger Carrillo, MD ; Juan Garisto, MD

12:30 PM

561

Ventricular Shunt Infections: Effects of Peri-Operative Antimicrobial Regimen on Etiology, Susceptibility and Response to Treatment
Jessica Nichols, MD ; Stephanie Stovall, MD

12:30 PM

562

Comparative Cost Analysis of Two Strategies for Preoperative Use of Mupirocin in Prosthetic Joint Replacement Patients
Marian Bihrle, BA ; Kathryn Kirkland, MD, FSHEA

12:30 PM

563

Inflammatory Blood Laboratory Levels as Markers of Prosthetic Joint Infection: A Systematic Review and Meta-analysis
Elie Berbari, MD ; Pat Erwin, MLS ; Tad Mabry, MD ; Hassan Murad, MD ; Douglas Osmon, MD ; Mark Spangehl, MD ; James Steckelberg, MD, FIDSA ; Geoffrey Tsaras, MD

12:30 PM

564

Prior Antimicrobial Therapy as a Risk Factor for Culture Negative Prosthetic Joint Infection: A Case-Control Study
Elie Berbari, MD ; Arlen Hanssen, MD ; Brian Lahr, MS ; Davud Malekzadeh,, can med5 ; Duffy Mary, RN ; Douglas Osmon, MD ; Jeanette Passow, PhD ; Robin Patel, MD, FIDSA ; Irene Sia, MD ; James Steckelberg, MD, FIDSA

12:30 PM

565

Entropy-based Source Attribution of Salmonella: Trends in Human Infection
Ezra Barzilay, MD ; Richard Bishop, AS ; Robert Hoekstra, PhD ; Colin Schwensohn, MPH

12:30 PM

566

Clinical and Economic Burden of Pneumococcal Disease in US Adults Aged 50 Years and Older
Lisa A. Jackson, MD, MPH ; Reiko Sato, PhD ; David Strutton, PhD, MPH ; Derek Weycker, PhD

12:30 PM

567

Estimates of the Indirect Burden of Invasive Meningococcal Disease: Insight from Public Health Officials
Bela Bapat, MA ; Timothy Bell, MSPH ; Sean Candrilli, PhD

12:30 PM

568

Health outcomes of nursing home residents colonized by antibiotic-resistant bacteria
Christopher Crnich, MD, MS ; Paul Drinka, MD ; Dennis Maki, MD, FIDSA ; David Zmmerman, PhD

12:30 PM

569

Economic Burden of Nosocomial Infection on Payers and Providers: Analysis of 272,143 Admissions in 2007
Stephen Brossette, MD, PhD ; Patrick Hymel, MD ; R Johannes, MD, MS ; Xiaowu Sun, PhD ; Ying Tabak, PhD

12:30 PM

570

Recent Patterns in Nosocomial and Community-Associated Infection Rates: Insights from a Nationwide Electronic Health Outcomes Database
Stephen Brossette, MD, PhD ; Emily Falk, MSPH ; Patrick Hymel Jr., MD ; Richard Johannes, MD, MS

12:30 PM

571

Air Port of Entry Surveillance: Passive or Active?
Joe Elm, MS ; Sarah Park, MD, FAAP ; Ranjani Rajan, MPH ; Hirokazu Toiya, MPH

12:30 PM

572

Incidence of Surgical Site Infection (SSI) Associated with Robotic Surgery
Elizabeth Hermsen, PharmD ; Tim Hinze, PharmD ; Mark Rupp, MD, FIDSA ; Harlan Sayles, MS ; Lee Sholtz, RN